News
Cellply Joins the NextGenNK Competence Center at Karolinska Institutet to Accelerate Next-Generation Cancer Immunotherapies
18 June 2026
Exposing the “Serial Killers”: Cellply to present breakthrough Single-Cell Data at ICLE 2026
Events
Exposing the “Serial Killers”: Cellply to present breakthrough Single-Cell Data at ICLE 2026
Cellply will be an official exhibitor at the 6th International Conference on Lymphocyte Engineering (ICLE 2026), happening July 15–17, 2026, in Milan, Italy.
We will be on-site at the San Raffaele Congress Center to showcase how our analytical technology is empowering researchers to evaluate cellular therapies with unprecedented speed and depth.
Beyond our exhibition booth, our scientific team will be presenting a poster that hits at the very core of advanced cell therapy characterization.
Poster Title: “Rapid understanding of functional heterogeneity and serial killing function of cellular therapies, with single-cell resolution, at scale”
Come to meet us: BOOTH #5
continue reading
You may also like
Press release
Cellply appoints Dr. Priyanka Dutta-Passecker as Chief Business Officer to drive global commercial expansion
3 June 2026
Press release
Cellply secures €7.15 million in funding and opens round extension to accelerate global expansion
8 May 2026
Press release
Unique CAR-T serial killing dynamics revealed using VivaCyte novel assay
4 November 2025
Press release
Karolinska Institutet and Cellply announce collaboration to advance NK cell-based therapy translational research with the VivaCyte platform
9 May 2025
Webinar
Webinar: A new automated potency analysis technique for suspension cells
25 November 2024
Events
Cellply Named in Cohort 2 of EIC Scaling Club for EU Deep Tech Scale-ups
6 November 2024
Press release
Cellply Introduces Revolutionary High-Throughput Potency Analysis Technique at SITC 39th Annual Meeting
31 October 2024
Webinar
Webinar: Uncovering hidden immune cell killing to understand anti-tumor activity
2 October 2024
Webinar
Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte
9 September 2024
News
Eurofins Biopharma Product Testing (BPT) Italy and Cellply announce strategic partnership to foster cell and gene therapy development through single-cell characterisation
29 August 2024
Webinar
Webinar: Rapid single cell functional characterization for cell therapy potency
12 July 2024
News
Cellply passed the phase 2 of Call4Innovit program and will go to San Francisco
23 May 2024
Events
Advancing TCR-based Cell Therapies & Bispecific Approaches
24 April 2024
Press release
Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development
19 March 2024
Events
Dual attendance for Cellply at March’s leading events in the cell therapy industry.
18 March 2024
Events
Launch of VivaCyte® at Advanced Therapies Week 2024
26 January 2024
News
Cellply launches its end-to-end single cell potency characterization platform VivaCyte
17 January 2024
Events
Cellply at Advanced Therapies Week 2024
4 January 2024
News
Cellply – Fesr programme 2021-2027
28 December 2023
Press release
Cellply concludes a new internal round of €3.6 million and extends the round to new investors!
27 September 2023
News
CellPly announces acceptance of one abstract at the CICON23 conference
18 September 2023
Press release
CellPly announces Emiliano Spagnolo as the new CEO
27 July 2023
News
L’innovazione Cellply in un articolo sulla rivista Le Scienze
4 March 2020
Events
Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting
25 November 2019
News
Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize
22 November 2018
Events
Cellply invited to present at the World Health Summit 2019
22 October 2018
News
Cellply selected as finalist at Lyfebulb Oncology Award
1 March 2018
Events
Cellply abstract accepted at the AACR 2018 Annual Meeting
4 February 2018
Press release
Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting
4 November 2016
News
Cellply wins an H2020 SME Instrument Phase 1 grant
20 October 2016
Keep in touch
Need some infos?
Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.